News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Peterson Amy C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Peterson Amy C. (EVP Prod Dev & Med Aff & CMO) has filed a Form 4 on EXELIXIS, INC.|
Txns:
| Granted 240,000 shares
@ $0
Granted 160,000 options to buy
@ $21.75, valued at
$3.5M
|
|
| 08/25/2023 |
3
| Peterson Amy C. (EVP Prod Dev & Med Aff & CMO) has filed a Form 3 on EXELIXIS, INC. |
| 03/20/2023 |
4
| Peterson Amy C. (EVP, Chief Development Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 4,257 shares
@ $1.979, valued at
$8.4k
|
|
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Peterson Amy C. (EVP, Chief Development Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 40,000 shares
@ $0
Granted 200,000 options to buy
@ $4.13, valued at
$826k
|
|
| 10/26/2021 |
4
| Peterson Amy C. (EVP, Chief Development Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.34, valued at
$267k
Granted 40,000 options to buy
@ $0 |
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2020 |
4
| Peterson Amy C. (EVP, Chief Development Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 3,101 shares
@ $6.392, valued at
$19.8k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2019 |
4
| Peterson Amy C. (EVP, Chief Development Officer) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 400,000 options to buy
@ $7.16, valued at
$2.9M
|
|
| 10/16/2019 |
3
| Peterson Amy C. (EVP, Chief Development Officer) has filed a Form 3 on CytomX Therapeutics, Inc. |
| 12/19/2018 |
4
| Peterson Amy C. (CMO, Immuno-oncology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Exercised 9,859 shares
@ $29.1, valued at
$286.9k
Sold 900 shares
@ $130.3678, valued at
$117.3k
Sold 2,700 shares
@ $131.7972, valued at
$355.9k
Sold 1,700 shares
@ $132.9137, valued at
$226k
Sold 1,005 shares
@ $133.8095, valued at
$134.5k
Sold 778 shares
@ $135.0446, valued at
$105.1k
Sold 2,296 shares
@ $136.2446, valued at
$312.8k
Sold 480 shares
@ $136.93, valued at
$65.7k
Exercised 10,141 shares
@ $29.1, valued at
$295.1k
Sold 1,631 shares
@ $131.735, valued at
$214.9k
Sold 1,897 shares
@ $132.7018, valued at
$251.7k
|
|
| 11/13/2018 |
4
| Peterson Amy C. (CMO, Immuno-oncology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Exercised 14,711 shares
@ $29.1, valued at
$428.1k
Sold 466 shares
@ $122.8565, valued at
$57.3k
Sold 2,423 shares
@ $124.4759, valued at
$301.6k
Sold 3,949 shares
@ $126.0773, valued at
$497.9k
Sold 7,673 shares
@ $126.7197, valued at
$972.3k
Sold 200 shares
@ $127.6075, valued at
$25.5k
Exercised 13,222 shares
@ $29.1, valued at
$384.8k
Sold 4,031 shares
@ $118.635, valued at
$478.2k
Sold 1,725 shares
@ $119.2694, valued at
$205.7k
Sold 2,100 shares
@ $120.631, valued at
$253.3k
Sold 2,898 shares
@ $121.7059, valued at
$352.7k
|
|
| 08/24/2018 |
4
| Peterson Amy C. (CMO, Immuno-oncology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 1,108 shares
@ $167.536, valued at
$185.6k
Sold 2,300 shares
@ $168.9414, valued at
$388.6k
Sold 1,400 shares
@ $169.7543, valued at
$237.7k
Sold 961 shares
@ $170.4634, valued at
$163.8k
|
|
| 06/28/2018 |
4
| Peterson Amy C. (CMO, Immuno-oncology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 44,564 shares
@ $0
Granted 310,180 options to buy
@ $0 |
|
| 11/15/2017 |
4
| Peterson Amy C. (CMO, Immuno-oncology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 2,400 shares
@ $82.7887, valued at
$198.7k
Sold 1,201 shares
@ $83.3091, valued at
$100.1k
|
|
| 08/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/24/2016 |
4
| Peterson Amy C. (CMO, Immuno-oncology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 300,000 shares
@ $0
Granted 1,600,000 options to buy
@ $2.24, valued at
$3.6M
|
|
| 08/24/2016 |
3
| Peterson Amy C. (CMO, Immuno-oncology) has filed a Form 3 on BeiGene, Ltd. |
|
|